BioSpace News Archive

Business

KBI Biopharma, Inc. Releases Inaugural FIH Manufacturing Batch at Integrated Switzerland Facility Five Months After Opening

KBI Biopharma, Inc. announced that late in 2022, it successfully released its inaugural First In Human manufacturing batch in compliance with current Good Manufacturing Practice standards in its recently expanded Geneva mammalian cell manufacturing facility.

March 21, 2023
·
3 min read
Business

NeuPath Announces Preliminary Financial Results for Fiscal 2022

NeuPath Health Inc. is pleased to provide an update with selected preliminary unaudited results for the fourth quarter of 2022 and the full year ended December 31, 2022.

March 21, 2023
·
5 min read
Lone Star Bio

Reminder: Coya Therapeutics to Host Conference Call Presenting Positive Clinical Data of COYA 302 in Patients with Amyotrophic Lateral Sclerosis (ALS) Today at 8:00am ET

Coya Therapeutics, Inc. today announced it will host a conference call to present positive clinical data announced earlier today, of Coya’s proprietary investigational biologic combination, COYA 302, in patients with Amyotrophic Lateral Sclerosis (ALS), today at 8:00am ET.

March 21, 2023
·
7 min read
Policy

Notice of Compliance issued regarding Rezurock(TM) (belumosudil tablets)

sanofi-aventis Canada Inc. is pleased to announce that Health Canada has issued a Notice of Compliance for Rezurock™, for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy.

March 21, 2023
·
3 min read
Genetown

Inhibikase Therapeutics to Present at the International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders

Inhibikase Therapeutics, Inc. today announced that Milton Werner will present at the International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD™), being held in Gothenburg, Sweden, and virtually, from March 28-April 1, 2023.

March 21, 2023
·
4 min read
280Bio Provides Update on the KRAS Inhibitor TEB-17231 at the 2023 AACR Annual Meeting

280Bio, Inc. today announced a presentation featuring the Company’s lead development candidate TEB-17231 at the AACR Annual Meeting in Orlando, Florida to be held April 14-19, 2023.

March 21, 2023
·
3 min read
BioForest

Immunexpress to Present Data at ISICEM 2023 Indicating that SeptiCyte® RAPID Outperforms Other Rapid Measures for Sepsis Diagnosis

Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today a poster presentation at the 2023 International Symposium on Intensive Care and Emergency Medicine.

March 21, 2023
·
5 min read
Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration with University of Alabama at Birmingham

Diamond Therapeutics Inc. (“Diamond”), a drug development company focused on low-dose psychedelic-derived therapies for use in the treatment of mental health, is pleased to announce the FDA’s authorization of the IND application submitted by collaborator Dr. Peter Hendricks.

March 21, 2023
·
5 min read
Deals

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome.

March 21, 2023
·
6 min read
Genetown

Lumicell Submits New Drug Application for LUMISIGHT™ Optical Imaging Agent to U.S. FDA for Intraoperative Breast Cancer Detection and Removal

Lumicell, Inc. today announced a New Drug Application (NDA) for its LUMISIGHT™ Optical Imaging Agent has been submitted to the U.S. Food and Drug Administration (FDA).

March 21, 2023
·
5 min read